Jian Jiang's team at the Institute of Chemistry, Chinese Academy of Sciences, recently published an article that focuses on the core bottlenecks of ...

Bill marks a decisive shift from reactive recovery to proactive, institutionalised resilience-building, positioning the ...

AI capabilities within pharma are evolving from add-on to an arm of core business demanding overhauled AI governance.

New from AASA: certification programs for superintendent-level coaching and equipping students with the executive function ...

Niki Sotiropoulou joins as Chief Marketing Officer and Sean Mooney as Vice President of Engineering, reinforcing XTM's commitment to AI-driven product innovation and global enterprise growth.

By Michael Krallmann, CEO, TransLegal. For the legal tech community, cross-jurisdictional meaning raises questions of risk, liability and trust. Increasingly capable models, wrapped in ...

Hospitals and health systems in 2026 are staring down a financial reckoning. With margin pressure mounting from every direction in the form of rising labor costs, reimbursement uncertainty and growing ...

In SYNCHRONIZE-1, participants lost up to an average of 39.2 lb (17.8 kg) from baseline after 76 weeks of treatment with survodutide, a ...

The card will operate on the Visa network, enabling users to spend USD at all merchant stores worldwide that accept Visa ...

No. 10 / 2026Zealand Pharma announces Boehringer Ingelheim's novel glucagon/GLP-1 dual agonist survodutide achieved ...